A Double-Blind Study to Evaluate the Pharmacodynamic Interaction Between 10 mg Vardenafil ODT (Orally Disintegrating Tablet) and Procardia (Nifedipine GITS) in Elderly Male Patients With Both Hypertension and Erectile Dysfunction.

Trial Profile

A Double-Blind Study to Evaluate the Pharmacodynamic Interaction Between 10 mg Vardenafil ODT (Orally Disintegrating Tablet) and Procardia (Nifedipine GITS) in Elderly Male Patients With Both Hypertension and Erectile Dysfunction.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Jul 2014

At a glance

  • Drugs Vardenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Pharmacodynamics
  • Sponsors Bayer
  • Most Recent Events

    • 05 Jan 2012 Actual patient number (42) added as reported by ClinicalTrials.gov.
    • 05 Jan 2012 Actual end date (December 2011) added as reported by ClinicalTrials.gov.
    • 05 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top